A novel kefir product (PFT) inhibits Ehrlich ascites carcinoma in mice via induction of apoptosis and immunomodulation.

Badr El-Din NK, Shabana SM, Abdulmajeed BA, Ghoneum M. A novel kefir product (PFT) inhibits Ehrlich ascites carcinoma in mice via induction of apoptosis and immunomodulation. BMC Complement Med Ther. 2020 Apr 28; 20(1):127.

View in: PubMed

subject areas

Animals
Apoptosis
Carcinoma, Ehrlich Tumor
Cell Cycle
Cell Line, Tumor
Cell Proliferation
Disease Models, Animal
Female
Immunomodulation
Mice
Probiotics

authors with profiles

Mamdooh H Ghoneum, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support